Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 13.04 is 236% above its 5-year average of 3.88, near the high end of its 5-year range (-16.60–13.04).
As of the fiscal period ended Tuesday, September 30, 2025. 66.97% above its 12-month average of 7.81.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
13.04
EARNINGS PER SHARE (EPS) AVG TTM
7.81
EARNINGS PER SHARE (EPS) AVG 3Y
8.10
EARNINGS PER SHARE (EPS) AVG 5Y
3.88
EARNINGS PER SHARE (EPS) AVG 10Y
3.88
EARNINGS PER SHARE (EPS) AVG 15Y
4.67
EARNINGS PER SHARE (EPS) AVG 20Y
3.79
CURRENT VS TTM AVG
+66.97%
CURRENT VS 3Y AVG
+61.04%
CURRENT VS 5Y AVG
+236.23%
CURRENT VS 10Y AVG
+235.69%
CURRENT VS 15Y AVG
+178.95%
CURRENT VS 20Y AVG
+244.38%
Cencora, Inc.
Market Cap
$62.18B
Earnings Per Share (EPS)
13.04
TTM Avg
7.81
3Y Avg
8.10
5Y Avg
3.88
Market Cap
$60.26B
Earnings Per Share (EPS)
3.95
TTM Avg
5.86
3Y Avg
5.65
5Y Avg
5.38
Market Cap
$68.46B
Earnings Per Share (EPS)
2.38
TTM Avg
1.61
3Y Avg
1.19
5Y Avg
0.89
Market Cap
$54.46B
Earnings Per Share (EPS)
6.54
TTM Avg
4.98
3Y Avg
1.97
5Y Avg
-0.44
Market Cap
$71.62B
Earnings Per Share (EPS)
41.04
TTM Avg
41.98
3Y Avg
40.38
5Y Avg
45.10
Market Cap
$48.18B
Earnings Per Share (EPS)
1.88
TTM Avg
4.41
3Y Avg
3.40
5Y Avg
2.89
Market Cap
$44.93B
Earnings Per Share (EPS)
13.56
TTM Avg
11.97
3Y Avg
10.56
5Y Avg
9.63
Market Cap
$79.64B
Earnings Per Share (EPS)
23.58
TTM Avg
17.27
3Y Avg
18.45
5Y Avg
18.81
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cencora, Inc. (COR) | $62.18B | 13.04 | 7.81 | 8.10 | 3.88 |
| Becton, Dickinson and Company (BDX)vs › | $60.26B | 3.95 | 5.86 | 5.65 | 5.38 |
| Boston Scientific Corporation (BSX)vs › | $68.46B | 2.38 | 1.61 | 1.19 | 0.89 |
| Cardinal Health, Inc. (CAH)vs › | $54.46B | 6.54 | 4.98 | 1.97 | -0.44 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $71.62B | 41.04 | 41.98 | 40.38 | 45.10 |
| Edwards Lifesciences Corporation (EW)vs › | $48.18B | 1.88 | 4.41 | 3.40 | 2.89 |
| Humana Inc. (HUM)vs › | $46.67B | 9.35 | 9.94 | 15.54 | 18.41 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.93B | 13.56 | 11.97 | 10.56 | 9.63 |
| Cigna Corporation (CI)vs › | $79.64B | 23.58 | 17.27 | 18.45 | 18.81 |
| Elevance Health Inc. (ELV)vs › | $83.65B | 22.50 | 25.49 | 25.23 | 24.07 |
Trailing EPS (TTM)
$13.04
Forward EPS (Est.)
$17.78
P/E Ratio
23.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-09-30 | 8.02 |
| 2024-09-30 | 7.60 |
| 2023-09-30 | 8.62 |
| 2022-09-30 | 8.15 |
| 2021-09-30 | 7.48 |
| 2020-09-30 | -16.60 |
| 2019-09-30 | 4.07 |
| 2018-09-30 | 7.61 |
| 2017-09-30 | 1.67 |
| 2016-09-30 | 6.73 |
| 2015-09-30 | -0.62 |
| 2014-09-30 | 1.22 |
| 2013-09-30 | 1.88 |
| 2012-09-30 | 2.84 |
| 2011-09-30 | 2.59 |
| 2010-09-30 | 2.26 |
| 2009-09-30 | 1.67 |
| 2008-09-30 | 0.78 |
| 2007-09-30 | 1.27 |
| 2006-09-30 | 1.14 |
| 2005-09-30 | 0.75 |
| 2004-09-30 | 1.05 |
| 2003-09-30 | 1.01 |
| 2002-09-30 | 0.82 |
| 2001-09-30 | 0.55 |
| 2000-09-30 | 0.48 |
| 1999-09-30 | 0.33 |
| 1998-09-30 | 0.26 |
| 1997-09-30 | 0.23 |
| 1996-09-30 | 0.20 |